What’s more exciting than
World Cancer Day, on Feb. 4, 2015, a day that shines a light on this dreadful,
life-killing disease?
The
answer is the Food and Drug Administration’s (FDA) approval last week of a
ground-breaking drug for those who suffer with advanced, metastatic breast
cancer.
The
drug is Ibrance, (palbociclib), and I am proud to say that the Noreen Fraser
Foundation (NFF) has been recognized as a group that has put faith along with
resources into the development of this drug.
Needless
to say, Pfizer eventually saw the genius of this research and took on the development
challenge of committing $190 million to get the drug on the market.
The
clinical trials were so successful that the FDA agreed to fast-track the drug.
Researchers did not think it would be available to the public until next year, but it is here!
Just
when many women with breast cancer feel like giving up, either because they are not feeling well or simply are exhausted, they shall pull themselves together, have a pep-talk and wrestle themselves to the
ground, until they all agree to push forward and persevere.
No comments:
Post a Comment